[EN] 1,2-AZOLE DERIVATIVES WITH HYPOGLYSEMIC AND HYPOLIPIDEMIC ACTIVITY<br/>[FR] DERIVES 1,2-AZOLE PRESENTANT UNE ACTIVITE HYPOGLYCEMIQUE ET HYPOLIPIDEMIQUE
申请人:TAKEDA CHEMICAL INDUSTRIES LTD
公开号:WO2003099793A1
公开(公告)日:2003-12-04
A compound represented by the formula (1) wherein ring A is a ring optionally having 1 to 3 substituents; ring B is a 1,2-azole ring which may further have 1 to 3 substituents; Xa, Xb and Xc are the same or different and each is a bond, - O -, - S - and the like; Ya is a divalent aliphatic hydrocarbon residue having 1 to 20 carbon atoms; Yb and Yc are the same or different and each is a bond or a divalent aliphatic hydrocarbon residue having 1 to 20 carbon atoms; ring C is a monocyclic aromatic ring which may further have 1 to 3 substituents; and R represents -OR4 (R4 is hydrogen atom or optionally substituted hydrocarbon group) and the like, or a salt thereof or a prodrug thereof is useful as an agent for the prophylaxis or treatment of diabetes and the like.
A series of new benzoxazepine derivatives substituted with different alkoxy and aryloxy group were synthesized comprising synthetic steps of Mitsunobu reaction, lithiumaluminumhydride (LAH) reduction, followed by debenzylation and finally intramolecular Mitsunobu cyclization. The new benzoxazepines specifically inhibited growth of breast cancer cell lines, MCF-7 and MDA-MB-231, but lack cytotoxicity
合成了一系列新的被不同烷氧基和芳氧基取代的苯并氮杂品衍生物,包括Mitsunobu反应的合成步骤,氢化铝锂(LAH)的还原步骤,随后的脱苄基作用以及最后的分子内Mitsunobu环化反应。新的苯并a氮平能特异性抑制乳腺癌细胞MCF-7和MDA-MB-231的生长,但对正常的HEK-293细胞没有细胞毒性。活性化合物诱导的细胞生长抑制是由于细胞周期停滞在G 0 / G 1期。该活性化合物可导致裸鼠模型MCF-7异种移植瘤的肿瘤体积明显减少,其活性与柠檬酸他莫昔芬在16 mg kg -1时的活性相当。治疗30天的剂量。与他莫昔芬相比,已确定的该系列最有效的化合物作为乳腺癌的抗癌剂具有特定优势。
Modified Borohydride Agents, 1-Benzyl-4-aza-1-azoniabicyclo[2.2.2]octane Tetrahydroborate (BAAOTB) versus Tetrabutylammonium Tetrahydroborate (TBATB). Efficient, Selective, and Versatile Reducing Agents
作者:Habib Firouzabadi、Gholam Reza Afsharifar
DOI:10.1246/bcsj.68.2595
日期:1995.9
1-Benzyl-4-aza-1-azoniabicyclo[2.2.2]octane tetrahydroborate (BAAOTB) and tetrabutylammonium tetrahydroborate (TBATB) are used for the selective reductions of aldehydes, ketones, α,β-unsaturated carbonyl compounds, acid chlorides, azides, epoxides, and disulfides in t-BuOH and hexane/chloroform. ABBOAB with its rigid and bulky structure reacts more selectively than its analogue TBATB.
Neighboring Lithium-Assisted [1,2]-Wittig Rearrangement: Practical Access to Diarylmethanol-Based 1,4-Diols and Optically Active BINOL Derivatives with Axial and sp3-Central Chirality
synthetically useful diarylmethanol‐based 1,4‐diols and enantiomericallypure BINOL‐derived diols with axial and sp3‐central chirality has been developed through neighboring lithium‐promoted [1,2]‐Wittig rearrangement. The chirality transfer process shows a broad substrate scope in terms of the aromatic ether substituent, which allows access to a broad of range of chiral 1,1′‐binaphthalene‐2‐α‐arylmethanol‐2′‐ols
1, 2-Azole derivatives with hypoglycemic and hypolipidemic activity
申请人:Maekawa Tsuyoshi
公开号:US20060148858A1
公开(公告)日:2006-07-06
A compound represented by the formula (1) wherein ring A is a ring optionally having 1 to 3 substituents; ring B is a 1,2-azole ring which may further have 1 to 3 substituents; Xa, Xb and Xc are the same or different and each is a bond, —O—, —S— and the like; Ya is a divalent aliphatic hydrocarbon residue having 1 to 20 carbon atoms; Yb and Yc are the same or different and each is a bond or a divalent aliphatic hydrocarbon residue having 1 to 20 carbon atoms; ring C is a monocyclic aromatic ring which may further have 1 to 3 substituents; and R represents —OR
4
(R
4
is hydrogen atom or optionally substituted hydrocarbon group) and the like, or a salt thereof or a prodrug thereof is useful as an agent for the prophylaxis or treatment of diabetes and the like.